Literature DB >> 35239539

Comprehensive Monitoring in Patients with Dual Lumen Right Atrium to Pulmonary Artery Right Ventricular Assist Device.

Asad A Usman1, Audrey E Spelde, Michael Ibrahim, Marisa Cevasco, Christian Bermudez, Emily MacKay, Sameer Khandhar, Wilson Szeto, William Vernick, Jacob Gutsche.   

Abstract

Right ventricular assist devices (RVADs) can be used in patients with acute right heart failure. A novel device that has recently been deployed is the right atrium to pulmonary artery (RA-PA) dual lumen single cannula (DLSC). One of the limitations is that it occupies a large proportion of the right ventricular outflow tract and PA; therefore, standard continuous hemodynamic monitoring with a pulmonary artery catheter is commonly not used. Serial echocardiography is pivotal for device deployment, monitoring device position, assessing RV readiness for decannulation, and surveilling for short-term complications. We performed a retrospective case series of 24 patients with RA-PA DLSC RVAD assessing echocardiographic RV progression and vasoactive infusion requirements. The overall survival was 66.6%. The average vasoactive infusion score at the time of cannulation was 24.9 ± 43.9, at decannulation in survivors 4.6 ± 4.9 vs. 25.4 ± 21.5 in nonsurvivors, and 2.7 ± 4.9 at 48 hours post decannulation. On echocardiography, the average visual estimate of RV systolic function encoded (0 = none and 5 = severe) in survivors was 3.9 ± 1.2, 2.8 ± 1.6, 2.5 ± 1.7, and 2.8 ± 1.9, respectively, and in nonsurvivors 3.8 ± 1.6 and 3.4 ± 1.8, respectively. This demonstrated an RV systolic function improvement over time in survivors as opposed to nonsurvivors. This was also demonstrated in RV size visual estimate, respectively. Quantitatively, at the predefined four timepoints, the RV:LV, tricuspid annular plane systolic excursion, and fractional area change all improve over time and there is statistically significant difference in survivors versus nonsurvivors. In this study, we describe a cohort of patients treated with RA-PA DLSC RVAD. We illustrate the critical nature of echocardiographic measures to rate the progression of RV function, improvement in vasoactive infusion requirements, and ventilator parameters with the RA-PA DLSC.
Copyright © 2022 by the American Society for Artificial Internal Organs.

Entities:  

Year:  2022        PMID: 35239539      PMCID: PMC9579997          DOI: 10.1097/MAT.0000000000001684

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   3.826


  34 in total

1.  Two-dimensional assessment of right ventricular function: an echocardiographic-MRI correlative study.

Authors:  Nagesh S Anavekar; David Gerson; Hicham Skali; Raymond Y Kwong; E Kent Yucel; Scott D Solomon
Journal:  Echocardiography       Date:  2007-05       Impact factor: 1.724

2.  Extracorporeal Membrane Oxygenation for Patients With COVID-19 in Severe Respiratory Failure.

Authors:  Asif K Mustafa; Philip J Alexander; Devang J Joshi; Deborah R Tabachnick; Chadrick A Cross; Pat S Pappas; Antone J Tatooles
Journal:  JAMA Surg       Date:  2020-08-11       Impact factor: 14.766

Review 3.  Catecholamine cardiotoxicity.

Authors:  G Rona
Journal:  J Mol Cell Cardiol       Date:  1985-04       Impact factor: 5.000

Review 4.  Mechanical Circulatory Support of the Right Ventricle for Adult and Pediatric Patients With Heart Failure.

Authors:  Steven G Chopski; Nohra M Murad; Carson S Fox; Randy M Stevens; Amy L Throckmorton
Journal:  ASAIO J       Date:  2019-02       Impact factor: 2.872

5.  A Dual-Lumen Percutaneous Cannula for Managing Refractory Right Ventricular Failure.

Authors:  Bernice Badu; Michael T Cain; Lucian A Durham; Lyle D Joyce; Sakthi Sundararajan; Nunzio Gaglianello; David Ishizawar; Mitchell Saltzberg; Asim Mohammed; David L Joyce
Journal:  ASAIO J       Date:  2020-08       Impact factor: 2.872

6.  Mechanical circulatory support for right ventricular failure.

Authors:  Navin K Kapur; Vikram Paruchuri; Anand Jagannathan; Daniel Steinberg; Anjan K Chakrabarti; Duane Pinto; Nima Aghili; Samer Najjar; John Finley; Nicole M Orr; Michael Tempelhof; James O Mudd; Michael S Kiernan; Duc Thinh Pham; David DeNofrio
Journal:  JACC Heart Fail       Date:  2013-04-01       Impact factor: 12.035

7.  Validation of the Vasoactive-Inotropic Score in Pediatric Sepsis.

Authors:  Amanda M McIntosh; Suhong Tong; Sara J Deakyne; Jesse A Davidson; Halden F Scott
Journal:  Pediatr Crit Care Med       Date:  2017-08       Impact factor: 3.624

8.  Right ventricular assist device with an oxygenator using extracorporeal membrane oxygenation as a bridge to lung transplantation in a patient with severe respiratory failure and right heart decompensation.

Authors:  Dong Kyu Oh; Tae Sun Shim; Kyung-Wook Jo; Seung-Il Park; Dong Kwan Kim; Sehoon Choi; Geun Dong Lee; Sung-Ho Jung; Pil-Je Kang; Sang-Bum Hong
Journal:  Acute Crit Care       Date:  2019-04-08

9.  Echocardiographic assessment of the right heart in adults: a practical guideline from the British Society of Echocardiography

Authors:  Abbas Zaidi; Daniel S Knight; Daniel X Augustine; Allan Harkness; David Oxborough; Keith Pearce; Liam Ring; Shaun Robinson; Martin Stout; James Willis; Vishal Sharma
Journal:  Echo Res Pract       Date:  2020-02-27

10.  Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry.

Authors:  Ryan P Barbaro; Graeme MacLaren; Philip S Boonstra; Theodore J Iwashyna; Arthur S Slutsky; Eddy Fan; Robert H Bartlett; Joseph E Tonna; Robert Hyslop; Jeffrey J Fanning; Peter T Rycus; Steve J Hyer; Marc M Anders; Cara L Agerstrand; Katarzyna Hryniewicz; Rodrigo Diaz; Roberto Lorusso; Alain Combes; Daniel Brodie
Journal:  Lancet       Date:  2020-09-25       Impact factor: 79.321

View more
  1 in total

1.  The Evolution of Percutaneous Right Ventricular Support and Development of a Right Ventricular Mechanical Support Team Led by Cardiac Anesthesiologists.

Authors:  Asad Ali Usman; Audrey Elizabeth Spelde; Stuart Weiss; John G Augoustides; William Vernick; Jacob Gutsche
Journal:  J Cardiothorac Vasc Anesth       Date:  2022-05-27       Impact factor: 2.894

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.